Plants >
Fertilizers
JUS-96-002-01 (SOR/DORS):
Amendments to the Fertilizer Regulations -- Novel Supplements
HIS EXCELLENCY THE GOVERNOR GENERAL IN COUNCIL, on the recommendation
of the Minister of Canadian Food Inspection Agency, pursuant to section 5 of
the Fertilizers Act, is pleased hereby to amend the Fertilizers Regulations,
C.R.C., c. 666, in accordance with the schedule hereto.
SCHEDULE
1. The heading before section 2 of the French version of the Fertilizers
Regulations is replaced by the following:
definition and interpretation
2. (1) Section 2 of the Regulations is renumbered as subsection
2(1).
(2) Subsection 2(1) of the Regulations is amended by
adding the following in alphabetical order:
- "environment" means the components of the Earth and
includes
- air, land and water,
- all layers of the atmosphere,
- all organic and inorganic matter and living organisms, and
- the interacting natural systems that include components referred to in
paragraphs (a) to (c); (environnement)
- "novel supplement" means
- a supplement that is not registered and not exempt from registration,
or
- a supplement that is derived through biotechnology and has a novel trait;
(supplément nouveau)
- "novel trait", in respect of a supplement derived through
biotechnology, means a characteristic of the supplement that
- has been intentionally selected, created or introduced into a distinct,
stable population [of supplements] of the same species through a specific
genetic change, and
- based on valid scientific rationale, is not substantially equivalent, in
terms of its specific use and safety both for the environment and for human
health, to any characteristic of a similar supplement that is in use as a
supplement in Canada and is considered safe for use as a supplement in Canada;
(caractère nouveau)
- "release" means any discharge or emission of a supplement
into the environment or exposure of a supplement to the environment;
(dissémination)
(3) Section 2 of the Regulations is amended by adding the following after
subsection (1):
- (2) For the purposes of sections 23.1 to 23.4, a novel supplement is toxic
if it is entering or may enter the environment in a quantity or concentration
or under conditions
- having or that may have an immediate or long-term harmful effect on the
environment;
- constituting or that may constitute a danger to the environment on which
human life depends; or
- constituting or that may constitute a danger in Canada to human life or
health.
3. (1) Section 3 of the Regulations is renumbered as subsection
3(1).
(2) Subsection 3(1) of the Regulations is amended by
adding the word "and" at the end of paragraph (e), by striking out
the word "and" at the end of paragraph
(f) and by repealing paragraph (g)1.
(3) Section 3 of the Regulations is amended by adding
the following after subsection (1):
(2) Supplements that are imported into or manufactured in Canada for
experimental purposes are exempt from the Act and all provisions of these
Regulations except sections 23.1 to 23.4.
4. The Regulations are amended by adding the following after section
23:
Notification and Authorization of the release of Novel Supplements
23.1 (1) Subject to subsection (2), no person shall release a novel
supplement unless the person
- provides notification of the proposed release in writing to the Minister,
accompanied by the information set out in section 23.2;
- provides an undertaking in writing to the Minister to take responsibility
for and assume the costs of the safe disposal of the novel supplement and all
crops produced on the land or growing medium to which the novel supplement is
applied; and
- receives authorization from the Minister for the release pursuant to
section 23.3.
(2) Where the accompanying information that is required to be provided to
the Minister by paragraph (1)(a) in respect of the proposed release of a novel
supplement is the same as information that has already been provided to the
Minister before the coming into force of this section and sections 23.2 to
23.4, or that is provided on or after the coming into force of this section and
sections 23.2 to 23.4 in relation to another notification or authorization, the
information is not required to be provided again.
Information Requirements
23.2 (1) Subject to subsection (2), the accompanying information that is
required to be provided by a person to the Minister pursuant to paragraph
23.1(1)(a) is the following:
- the name of the person or body responsible for the proposed release and the
name of the person who will be in charge of carrying out the release;
- the purpose and objectives of the proposed release;
- the proposed starting date, time period and site of the release;
- the proposed release protocol, including
- any confinement measures intended to mitigate the establishment and spread,
in the environment, of the novel supplement and the interaction of the novel
supplement with the environment,
- the monitoring plan and procedures to be followed both during and after the
release,
- the method to be used for the safe disposal of the novel supplement and all
crops produced on the land or growing medium to which the novel supplement is
applied, and
- the contingency plan to be followed to mitigate any adverse effect of an
accidental release of the novel supplement on the environment, including any
adverse effect on human health;
- the identification and characterization of the novel supplement, including,
in the case of a novel supplement that is derived through biotechnology and has
a novel trait
- the identification and characterization of the novel trait expressed by the
novel supplement and, where the novel trait is introduced from another species,
details of the host and donor organism and of the methods of incorporation of
the novel trait into the novel supplement, where applicable, and
- the identification and characterization of the novel supplement resulting
from the introduction of the novel trait, including details relating to
expression of the novel trait and the stability of the incorporation of the
novel trait into the novel supplement, and a comparison of the characteristics
of the novel supplement with those of the unmodified supplement;
- all other information and test data in respect of the novel supplement that
are relevant to identifying the risk to the environment, including the risk to
human health, and that are in the person's possession or to which the
person ought reasonably to have access;
- other government agencies, either Canadian or foreign, that have been
provided with information in respect of the novel supplement, and the purpose
for which the information was provided; and
- a description of the analytical methodologies followed in generating any
submitted data, including quality control and quality assurance
procedures.
(2) The information required by paragraph (1)(e)(ii) or paragraph (1)(f) or
(h) or any part of that information may be omitted if the Minister determines,
on the basis of a written scientific rationale provided by the person referred
to in subsection (1), that the information or part is not relevant or cannot
practicably be obtained and is not required for the Minister's decision
under section 23.3, and notifies the person of that determination.
Decision of the Minister
23.3 (1) On receiving the notification provided pursuant to paragraph
23.1(1)(a), the Minister shall, after considering all relevant matters,
including the information provided pursuant to that paragraph, and after
evaluating the potential impact on and risk to the environment, including the
potential impact on and risk to human health, posed by the proposed release
- authorize the release where there is minimal risk to the environment, and
may, where necessary in order to minimize the risk, impose conditions for the
management of the risk; or
- refuse to authorize the release where the proposed release poses an
unacceptable risk to the environment.
(2) In evaluating the risk to the environment for the purposes of subsection
(1), the Minister shall
- consider such matters as
- the effects of the proposed release on the environment, and
- the magnitude of the exposure to the environment of the novel supplement
involved in the proposed release; and
- assess whether the novel supplement is toxic.
New Information Requirements
23.4 (1) Where, at any time after providing notification pursuant to
paragraph 23.1(1)(a) or receiving authorization pursuant to paragraph
23.3(1)(a), a person becomes aware of any new information regarding risk to the
environment, including risk to human health, that could result from the release
of the novel supplement, the person shall immediately provide the new
information to the Minister.
(2) Where the Minister, on the basis of the new information provided by a
person pursuant to subsection (1), re-evaluates the potential impact on and
risk to the environment, including the potential impact on and risk to human
health, posed by the release and determines that there is
- a risk that is less than was apparent at the time of the original
notification or at the time of any subsequent provision of new information
since the original notification, the Minister may
- where the release has already been authorized, maintain existing conditions
respecting the release;
- change the conditions respecting the release, or
- remove any of the conditions respecting the release;
- a risk that is greater than was apparent at the time of the original
notification or at the time of any subsequent provision of new information
since the original notification, the Minister may
- impose additional conditions respecting the release, or
- require release under different conditions; or
- an unacceptable risk, the Minister shall
- refuse to authorize the release, or
- where the release has already been authorized, cancel the authorization and
require the person to stop the release and to take any appropriate action
necessary to eliminate or minimize the risk.
(3) In re-evaluating the risk to the environment on the basis of new
information for the purposes of subsection (2), the Minister shall consider the
matters referred to in paragraph 23.3(2)(a) and make the assessment referred to
in paragraph 23.3(2)(b).
|